Amgen Q3 adjusted operating expenses $5,689 million
AMGN•Amgen reported Q3 adjusted operating expenses of $5,689 million, revenue of $10,365 million versus an IBES estimate of $10,071 million, and adjusted EPS of $6.45 versus an estimate of $5.79. It forecast full-year adjusted EPS of $22.90-$23.70 and revenue of $38,900-$39,700 million.
1. Quarterly results and outlook
Amgen reported Q3 revenue of $10,365 million, compared with an IBES estimate of $10,071 million, and adjusted EPS of $6.45, compared with an estimate of $5.79. Adjusted operating expenses were $5,689 million. The company forecast full-year adjusted EPS of $22.90-$23.70 and revenue of $38,900-$39,700 million.
